FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称ETESEVIMAB
异名/同义词ANTI-SARS-COV-2 ANTIBODY JS016
CB6
CB-6
ETESEVIMAB
ETESEVIMAB [INN]
ETESEVIMAB [USAN]
ETESEVIMAB [WHO-DD]
IMMUNOGLOBULIN G1 (236-ALANINE,237-ALANINE), ANTI-(SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 SPIKE GLYCOPROTEIN RECEPTOR-BINDING DOMAIN) (HUMAN MONOCLONAL JS016 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL JS016 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G1 (236-ALANINE,237-ALANINE), ANTI-(SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 SPIKE GLYCOPROTEIN) (HUMAN MONOCLONAL LY3832479 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL LY3832479 .KAPPA.-CHAIN, DIMER
JS016
JS-016
LY COV016
LY3832479
LY-3832479
LY-COV016
NP005
NP-005
CAS登记号2423948-94-9
物质唯一标识(Unique Ingredient Identifier)N7Q9NLF11I
分子式
国际化合物标识(International Chemical Identifier,InChI)
SMILES
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / protein
关联数据
  • 药品国际非专利名称数据库
  • 世界卫生组织药物词典
扩展资源
©2006-2024 Drugfuture->FDA Global Substance Registration System